Download:
pdf |
pdfCURRENT INDUSTRIAL REPORTS
2006
MA325G — PHARMACEUTICAL PREPARATIONS, EXCEPT BIOLOGICALS (MANUFACTURERS)
DEFINITIONS AND SPECIAL INSTRUCTIONS
Products bought and resold without further
manufacture should not be included in shipments.
1. Scope of survey
This survey covers manufacturers of pharmaceutical
preparations, except biologicals, in the United States,
and includes all preparations which can be dispensed
in measured portions to produce the therapeutic effect
for which the preparation is most commonly employed
(liquids, tablets, pills, capsules, lozenges, powders,
ointments, jellies, salves, inhaler tubes, etc.). Products
manufactured in Puerto Rico or other U.S. possessions
should be excluded.
Establishments shipping dosage forms, in bulk and
requiring repackaging, to other establishments of the
same company, should report in column (4) a transfer
value reflecting only services or operations performed
including profit (or loss) normally assigned to the
manufacturing establishment. For plants shipping
similar products to other companies for repackaging
report in column (4) dosage forms shipped in bulk at
net sales value as defined above.
2. Figures to be reported
Companies with more than one establishment
manufacturing the products covered by this survey are
requested to complete a separate report form for each
location. If you have not received a separate form for
each of your establishments, please call the contact
listed on the report form or write to the U.S. Census
Bureau for additional forms.
Operations for which data should be reported include:
Manufacturing drugs in packaged dosage form for
consumer use
Manufacturing drugs in dosage form and shipping in
"bulk" type containers for repackaging or for export
Commercial shipments (packaged for consumer use)
Report the value of each drug product produced
in dosage form, packaged for consumer use and
shipped from this establishment to sales branches,
warehouses of your company, wholesale or retail
stores, and other commercial customers such as
hospitals, institutions, etc.
Contract operations include shipments of products
made for others from your own materials. Exclude
receipts for capsulating and/or packaging of
preparations owned by others; companies for whom
such work is done should report value of shipments of
these products.
b. Units of measure
Compounding pharmaceutical preparations and
shipping dosage forms in "bulk"
Report values in thousands of dollars.
Please examine the reference list to determine which of
the listed pharmaceuticals are produced by you. If you
are unable to find a specific line which describes a drug
product, include this product in the not elsewhere
classified (n.e.c.) product category at the end of the
product grouping with which it is most closely
associated. In the "n.e.c." products categories, a
separate line should be used to describe and report
each major product. Describe each "n.e.c." product by
using common commercial name, generic name, or
other specific name, and enter any other name,
description, or use that will help to classify the product
using the "Remarks" section for additional space if
necessary.
a. Value of shipments
Report total value of shipments of each
pharmaceutical preparation sold, transferred to other
establishments within your company, or shipped on
consignment, whether for domestic or export sale.
Value represents the net sales price, f.o.b. plant, to the
customer or branch to which the products are shipped,
net of discounts, allowances, freight charges, and
returns. Shipments to your own branches should be
assigned the same value as comparable sales to
unaffiliated customers, i.e., the value includes an
appropriate allocation of company overhead and profit.
c. Columnar structure of report
When posting your figures to the original report, be
sure to report the information in the correct columns.
Column 1 (Total) — Report the sum of columns 2
through 4.
Column 2 (Prescription legend) — Report the value of
each drug product which by Federal Law is available
only by prescription from a licensed practitioner.
Column 3 (Non-prescription) — Report the value of
each non-prescription drug product shipped.
Column 4 (Bulk shipments) — Report the value of each
drug product shipped in dosage forms, or in bulk,
requiring only repackaging.
Note: Export shipments are to be included in these
figures.
3. Definitions
The product detail for this survey, as shown in the
Reference List is defined according to standard
nomenclature for this industry.
U S C E N S U S B U R E AU
Page 1 of 12
CURRENT INDUSTRIAL REPORTS
MA325G
DEFINITIONS AND SPECIAL INSTRUCTION — Continued
4. Comparability
If you also report in the Annual Survey of Manufactures (Form MA-10000), the
sum of values for item codes shown in column (a) should correspond to the
dollar values reported under product class codes indicated in column (b) below:
Current Industrial Reports
(Form MA325G)
Annual Survey of
Manufactures
Item codes
(a)
Product class codes
(b)
5113 through 5198
3254121
5211 through 5298
3254124
5325 through 5397
3254127
5412 through 5489
325412A
5511 through 5597
325412D
5611 through 5698
325412G
5711 through 5797
325412L
5811 through 5898
325412P
5911 through 5997
325412T
Page 2 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST
FORM
MA325G
Product
code
PHARMACEUTICAL PREPARATIONS, EXCEPT BIOLOGICALS (MANUFACTURERS)
Item
code
Item description
PHARMACEUTICAL PREPARATIONS AFFECTING NEOPLASMS, ENDOCRINE SYSTEM,
AND METABOLIC DISEASES, FOR HUMAN USE
Hormones and synthetic substitutes
*3254121114
5113
Corticoids, such as cortisone, desoxycorticosterone, hydrocortisone, and prednisone,
including systemic, local and topical (including anti-infective combinations)
3254121121
5117
Androgens (except anabolic agents, such as fluoxymesterone and methyltestosterone)
3254121126
5119
Estrogens, such as estradiol and estrone
3254121131
5121
Insulins and anti-diabetic agents such as glucagon and sulfonylureas
3254121141
5127
Oral contraceptive preparations (Report vaginal contraceptives in code 325412D191)
3254121146
5129
Progestogens, such as ethisterone and progesterone (Report premenstrual tension
preps in code 325412D193)
3254121156
5135
Thyroid and antithyroid preparations, such as iodides and propylthiouracil
3254121161
5137
Anabolic agents (synthetic and semisynthetic androgens employed primarily for anabolic
activity), such as nandrolone phenpropionate and norethandrolone
*3254121165
5138
Other hormone preparations, such as chorionic gonadotropin, parathyroids,
andvasopressin, ACTH (corticotropni), and sex hormone combinations (except
progestogen combinations)
Anti-neoplastic agents
Anti-neoplastic agents, including busulfan, chlorambucil, cyclophosphamide, vincristine
and antimetabolites (folic acid, purine, and glutamine antagonists), and radioactive
isotopes for internal use
*3254121177
5146
3254121181
5198
Other pharmaceutical preparations affecting neoplasms, the endocrine system and
metabolic diseases such as metabolic agents, parenteral fats, carbohydrates, and protein
preparations
3254121 --
5199
TOTAL, PHARMACEUTICAL PREPARATIONS AFFECTING NEOPLASMS, ENDOCRINE
SYSTEM, AND METABOLIC DISEASES, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM AND
THE SENSE ORGANS, FOR HUMAN USE
3254124111
5211
Parasympathomimetic cholinergic drugs (agents employed mainly for treatment of
myasthenia gravis) such as ambenonium, neostigmine, and pyridostigmine
3254124114
5213
Skeletal muscle relaxants such as methocarbamol and metaxalone
Internal analgesics and antipyretics (Report external analgesics in codes 325412G146 to
325412G161)
Narcotic, such as alphaprodine, meperidine, methadone, and morphine
3254124117
5219
3254124121
5220
Opium and derivatives
Synthetic narcotics
*New or Revised for 2006
Page 3 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM AND
THE SENSE ORGANS, FOR HUMAN USE — Continued
Internal analgesics and antipyretics (Report external analgesics in codes 325412G146 to
325412G161) — Continued
Non-narcotic
*3254124122
5221
Salicylates, including aspirin (acetylsalicylic acid), and others such as sodium
salicylate
3254124131
5225
Aspirin combinations
3254124134
5226
Acetaminophen and combinations
3254124137
5227
Anti-arthritics and anti-inflammatory agents (non-hormonal), such as flunisolide and
fluorometholone
3254124141
5228
3254124144
5241
Other internal analgesics and antipyretics, including effervescent types and
suppositories, such as acetophenetidin, and ethoheptazine
Anticonvulsants (except barbiturates and analogs) (for treatment of petit mal, grand mal,
psychomotor and focal epilepsy) such as phenytoin, ethotoin, paramethadione, and
methsuximide
Psychotherapeutic agents
3254124147
5251
Antidepressants (for treatment of pyschoneurotic depression, involutional melancholia,
the depressive phase of manic-depressive psychosis and the depression of
schizophrenia), such as imipramine hydrochloride, isocarboxazid, and maprotiline
Tranquilizers (for treatment of emotional instability and anxiety-tension states) (Report
sedatives in codes 3254124171 to 3254124181)
3254124151
5255
Phenothiazine derivatives, such as promazine, prochlorperazine, and thioridazine
3254124154
5257
Other tranquilizers, such as chorprothixene and molindone
3254124157
5259
*3254124165
5265
Other psychotherapeutic agents
Central nervous system stimulants, including amphetamine, anorexiants containing CNS
stimulants such as phenylpropanolamine hydrochloride (except amphetamines) (Report
diet aids containing local anesthetics in code 3254124189), and other, (respiratory and
cerebral stimulants, including sympathomimetic agents employed mainly as CNS
stimulants) (exclude nondrug dietaries for weight control)
*New or Revised for 2006
Page 4 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM AND
THE SENSE ORGANS, FOR HUMAN USE — Continued
Sedatives, anxiolytics and hypnotics (products primarily used for sedation) (Report
products combined with sedative agents under the primary therapeutic indication)
Prescription
3254124171
5271
Barbiturates, such as amobarbital, butabarbital, pentobarbital, and phenobarbital
3254124174
5275
Non-barbiturates, such as ethchlorvynol, glutethimide, and methyprylon .
*3254124178
5278
Non-prescription sleep inducers, excluding antihistamines, and calming agents such
as scopalomine
*3254124189
5287
Anesthetics (except urinary tract anesthetics and antipruritic skin preparations), including
general, local, and topical, such as proparacaine, piperocaine, benoxinate, and
ethylaminobenzoate (Report urinary tract anesthetics in code 325412D196, and
antipruritics in code 325412G116)
Eye and ear preparations, excluding anti-infectives corticoids, anti-bacterials, and
antiseptics (Report antibiotics, sulfonamides, and other anti-infectives in codes
325412P111 to 325412P174; local and topical corticoid preparations in code 3254121116;
and anti-bacterials and antiseptics, including mouthwashes and gargles in codes
325412P177 and 325412P181)
3254124193
5293
Contact lens solutions
*3254124196
5295
Other eye and ear preparations, including mydriatics and miotics
3254124197
5298
Other pharmaceutical preparations acting on the central nervous system and the sense
organs
3254124 --
5299
TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS
SYSTEM AND THE SENSE ORGANS, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE CARDIOVASCULAR SYSTEM, FOR
HUMAN USE
*3254127118
5325
Anticoagulants (for the prophylaxis and treatment of intravascular clotting, thrombophlebitis
pulmonary embolism, arterial thromboses, and coronary occlusion) such as anisindione,
heparin, and warfarin, hemostatics (for control of capillary, venous, or arterial bleeding)
such as thrombin and aminocaproic acid), and digitalis preparations such as digitalis,
digitoxin, and digoxin
*New or Revised for 2006
Page 5 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS ACTING ON THE CARDIOVASCULAR SYSTEM, FOR
HUMAN USE — Continued
Hypotensives
*3254127128
5345
Hypotensives such as guanethidine, hydralazine, and methyldopa, rauwolfia-alkaloid
preparations such as reserpine and rescinnamine, and rauwolfia-diuretic combinations,
and beta receptor blocking agents, such as propanolol hydrochloride
Vasodilators
3254127143
5353
Coronary (for treatment of angina pectoris), including amylnitrite, erythrityl tetranitrate,
and pentaerythritol tetranitrate, and peripheral (for relief of vasospasm), including
isoxuprine and cyclandelate
3254127151
5361
Anti-arrhythmics, such as propanolol and quinidine
3254127156
5371
Calcium channel blockers such as isoptin, calan, procardia, cardizem and adalat
3254127161
5381
Ace inhibitors such as vasotec, capoten, prinivil and zestril
3254127166
5397
Other pharmaceutical preparations acting on the cardiovascular system, including
vasopressors, and antiheparin agents
3254127 --
5399
TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE CARDIOVASCULAR
SYSTEM, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE RESPIRATORY SYSTEM, FOR
HUMAN USE
*325412A113
5412
Antihistamines (except cold preparations and anti-emetics) such as brompheneramine,
diphenhydramine, diphenylpyraline, and chlorpheneramine maleate, and bronchial dilators,
including antiasthmatics (for the relief of bronchial spasm or congestion such as
theophyllin)
Cough and cold preparations (prescription)
*325412A123
5423
Cough preparations and expectorants (containing an antitussive or other ingredient
intended primarily to treat cough only), including non-narcotic, and narcotic such as
benzonatate, glycerylguaiacolate, terpin hydrate, codeine, and hydro codeine
Cold preparations (containing combinations of the following ingredients, (but no
antitussive) nasal decongestant, antihistamine, analgesic, bioflavanoid, or antibiotic)
325412A136
5435
Antihistamine cold preparations, such as tripelennamine and cyproheptadine
*325412A143
5438
Other prescription cold preparations, including nasel decongestants, such as
proplhexadrine
325412A146
5441
Cough and cold combinations (prescription)
*New or Revised for 2006
Page 6 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS ACTING ON THE RESPIRATORY SYSTEM, FOR
HUMAN USE — Continued
Cough and cold preparations (non-prescription)
*325412A153
5452
325412A166
5461
Decongestants, including nasal sprays, nose drops, and others
325412A171
5463
Cough syrups
325412A176
5465
Capsules and tablets
*325412A189
5478
Lozenges
*325412A196
5489
Other non-prescription cough and cold preparations, including topical preparations, and
cough drops
325412A –
5499
Other pharmaceutical preparations acting on the respiratory system, including beta
agonists such as proventil and ventolin
TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE RESPIRATORY
SYSTEM, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE DIGESTIVE OR THE GENITOURINARY SYSTEMS, FOR HUMAN USE
Digestive system preparations
325412D111
*325412D115
5511
Enzymes such as amylase, lipase, cellulase
5517
Antacids, including acid neutralizing products and products with coating functions, but
excluding effervescent salicylate products classified as analgesics, such as aluminumhydroxide, calcium carbonate, dihydroxy aluminum aminoacetate, and aluminumphosphate (Report internal analgesics in code 3254124141), and antidiarrheals such as
bismuth subcarbonate (except narcotics)
Laxatives such as bisacodyl, cascara sagrada, castor oil, danthron, dioctyl sodium
sulfosuccinate, magnesium sulfate, methylcellulose, sodium carboxymethylcellulose, and
petrolatum (liquid)
5521
5522
Irritants
5525
Fecal softeners
325412D134
5528
Saline
325412D137
5529
Enema specialties
325412D121
*325412D123
325412D127
Bulk producing, and emollients
*New or Revised for 2006
Page 7 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS ACTING ON THE DIGESTIVE OR THE GENITOURINARY SYSTEMS, FOR HUMAN USE — Continued
Digestive system preparations — Continued
Antispasmodics and anticholinergics, including ataractic combinations, belladonna and
derivatives, and H2 blocking agents such as zantec, tagamet, carafate, and pepcid
325412D157
5541
Synthetics (such as adiphenine, anisotropine, dicyclomine, and papaverine)
*325412D168
5548
Antispasmodics and anticholinergics, including ataractic combinations, belladonna and
derivatives, and H2 blocking agents such as zantec, tagamet, carafate, and pepcid
*325412D175
5559
Other digestive system preparations, including emetics such as ipecac, including
digestants; bile therapy preparations, including bile products, choleretics, and
cholagogues; antinauseants and motion sickness remedies (anti-emetics), including
antihistaminic anti-emetic preparations; lipotropics and cholesterol reducers; and diet
aids containing local anesthetics such as benzocaine. (Report anorexiants containing
CNS in codes 3254124165)
Genito-urinary preparations
325412D177
5561
Urinary antibacterials and antiseptics such as methenamine mandelate, and
nitrofurantoin
*325412D182
5575
Diuretics, including chlorthalidone, ethacrynic acid, and triampterene, thiazides, and
related agents such as chlorothiazide, hydrochlorothiazide, and hydroflumethiazide
(Report aminophylline, xanthine, and rauwolfia-diuretic combinations ascardiovascular
preparations)
325412D187
5581
Oxytocics such as ergonovine and oxytocin
325412D195
5587
Vaginal cleansers (Report trichomonacides in code 325412P111, fungicides in code
325412P167, and antibacterials in code 325412P177)
*325412D196
5597
Other pharmaceutical preparations acting on the genito-urinary system, including urinary
tract anesthetics, including premenstrual tension preparations, and contraceptive agents
(aerosols, jels, sponges, and creams)(Report oral in code 3254121141)
325412D --
5599
TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE DIGESTIVE OR THE
GENITO-URINARY SYSTEMS, FOR HUMAN USE
*New or Revised for 2006
Page 8 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS ACTING ON THE SKIN, FOR HUMAN USE
Dermatological preparations
325412G111
5611
Emollients and protectives, including burn remedies and ointment bases
325412G116
5613
Antipruritics and local anesthetic skin preparations (products used primarily to alleviate
itching), such as cyclomethylcaine and benzocaine
325412G126
5616
Antiacne preparations
325412G131
5618
Antidandruff and antiseborrheic preparations (except dandruff shampoos)
*325412G138
5620
Other dermatological preparations, including coal tar, sulfur, and resorcinol preparations
325412G141
5621
Hemorrhoidal preparations
*325412G163
5638
External analgesics and counter irritants, including ointments, jellies, pastes, creams,
cerates, salves, liquids, and rubbing alcohol
325412G166
5698
Other pharmaceutical preparations acting on the skin
325412G --
5699
TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE SKIN, FOR HUMAN USE
VITAMIN, NUTRIENT, AND HEMATINIC PREPARATIONS, FOR HUMAN USE
Vitamins
325412L111
5711
Multivitamins, plain and with minerals (except B complex vitamins and fish liver oils)
325412L116
5713
Pediatric vitamin preparations (drops, suspensions, and chewable tablets)
325412L121
5714
Prenatal vitamin preparations
325412L126
5715
B complex preparations
*325412L135
5718
All other vitamin preparations, including fluoride preparations (Report fluoride-vitamin
combinations in applicable code 315412L116, 325412L121, or 325412L135)
325412L141
5721
Fish liver oils
325412L146
5731
Nutrients, excluding therapeutic dietary foods and infant formulas
325412L151
5741
Tonics and alteratives
Hematinic
*325412L158
5752
Oral, and parenteral, with B12
*New or Revised for 2006
Page 9 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
VITAMIN, NUTRIENT, AND HEMATINIC PREPARATIONS, FOR HUMAN USE — Continued
Hematinics — Continued
*325412L168
5756
*325412L179
5797
Other vitamin, nutrient, and hematinic preparations, including hospital solutions,
including dextrose, dextran, etc., but excluding biologicals such as blood plasma)
325412L--
5799
TOTAL, VITAMIN, NUTRIENT AND HEMATINIC PREPARATIONS, FOR HUMAN USE
Other hematinics, including oral, and parenteral
PHARMACEUTICAL PREPARATIONS AFFECTING PARASITIC AND INFECTIVE DISEASES,
FOR HUMAN USE
Anti-infective agents (Report corticoid-anti-infective combinations in code 3254121116)
325412P111
5811
Amebicides and trichomonicides such as diiodohydroxyquin, emetine, metronidiazole, and
furazolidone
325412P114
5815
Anthelmintics (for roundworms, hookworms, pinworms, whipworms, and tapeworms) such
as dithiazanine, hexylresorcinol, piperazine, and tetrachloroethylene
Systemic antibiotic preparations
Broad and medium spectrum (single or in combinations with other antibiotics)
325412P117
5820
Tetracyclines, including chlortetracycline and congeners
325412P121
5822
Cephalosporins, such as cefamandole nafate and cephalexin
325412P124
5824
Erythromycins
Penicillins (single)
Semisynthetic penicillins, such as amoxicillins and ampicillin
325412P127
5826
Injectable
325412P131
5828
Other forms
*325412P135
5831
325412P141
5834
Other broad and medium spectrum antibiotics (except sulfa-antibiotic combinations)
325412P144
5836
Antibiotics in combination with sulfonamides
325412P147
5838
Other systemic antibiotic preparations, including narrow-spectrum antibiotics and
streptomycins
325412P151
5841
Topical antibiotic preparations
Other penicillins, injectable and other forms (except semisynthetic),
such as penicillin V and penicillin G
*New or Revised for 2006
Page 10 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS AFFECTING PARASITIC AND INFECTIVE DISEASES,
FOR HUMAN USE — Continued
Anti-infective agents (Report corticoid-anti-infective combinations in code 3254121116) —
Continued
*325412P156
5853
Tuberculostatic agents, including isoniazid (isonicotinic acid hydrazide) preparations,
aminoslicylic acid, capreomycin, and cycloserine
325412P161
5861
Antimalarials (plasmodicides) such as chloroquine, primaquine, pyrimethamine, and
quinine
325412P164
5863
Sulfonamides, such as sulfamerazine, sulfamethizole, and sulfadiazine (except sulfaantibiotic combinations)
325412P167
5865
Antifungal preparations such as iodochlorhydroxyquin
325412P171
5867
Antivirals, systemic, such as zovirax and retrovir
325412P174
5869
Other anti-infective agents
Antibacterials and antiseptics (Report urinary preparations in code 325412D177,
antibiotics in codes 325412P117 to 325412P151, and sulfonamides in code 325412P164)
325412P177
5871
General
325412P181
5875
Mouth and throat preparations, including mouthwashes and gargles
325412P184
5898
Other pharmaceutical preparations affecting parasitic and infective diseases
325412P --
5899
TOTAL, PHARMACEUTICAL PREPARATIONS AFFECTING PARASITIC AND INFECTIVE
DISEASES, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS FOR VETERINARY USE
(Note: INCLUDE drug and vitamin pre-mixes for use in animal feeds; EXCLUDE
supplements, concentrates, and complete feeds)
325412T111
5911
Anesthetics
325412T116
5921
Anthelmintics
Antibiotics
325412T126
5924
Penicillins
*325412T133
5925
Other antibiotics, including tetracyclines
325412T136
5927
Antiseptics, wound dressings and fungicides
*325412T163
5937
Hormones, including insulin, ACTH (corticotropin), and other hormone preparations
*New or Revised for 2006
Page 11 of 12
CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM
MA325G
Product
code
Item
code
Item description
PHARMACEUTICAL PREPARATIONS FOR VETERINARY USE — Continued
325412T171
5941
Nitrofurans
325412T176
5943
Nutrients and tonics
325412T181
5945
Parasiticides, external
*325412T196
5997
Other pharmaceutical preparations for veterinary use, including vitamins, minerals,
tranquilizers, ataractics, sulfonamides, intravenous solutions, electrolytes, hemostatics,
and hematinics
325412T --
5999
TOTAL, PHARMACEUTICAL PREPARATIONS FOR VETERINARY USE
NOTES:
10/31/06
*New or Revised for 2006
Page 12 of 12
File Type | application/pdf |
File Title | MA325G - Pharmaceutical Preparations, Except Biologicals (Manufacturers) |
Subject | 2006 |
Author | U.S. Census Bureau |
File Modified | 2007-03-07 |
File Created | 2007-03-07 |